Johnson & Johnson
NYSE:JNJ
Johnson & Johnson
NYSE:JNJ
Price:
148.92 USD
0.23%
Market Closed
Updated:
May 7, 2024
Johnson & Johnson
Cash from Financing Activities
|
Johnson & Johnson
Cash from Financing Activities Peer Comparison
Comparables:
BMY
PFE
MRK
ZTS
LLY
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Financing Activities
-$21.4B
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-10%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Financing Activities
$8.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Financing Activities
$26.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Financing Activities
-$5.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
-7%
|
|
|
Zoetis Inc
NYSE:ZTS
|
Cash from Financing Activities
-$1.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-31%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Financing Activities
$2.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Johnson & Johnson's Cash from Financing Activities?
Cash from Financing Activities
-21.4B
USD
-21.4B
USD
Based on the financial report for Mar 31, 2024, Johnson & Johnson's Cash from Financing Activities amounts to -21.4B USD.
What is Johnson & Johnson's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-10%
-10%
The average annual Cash from Financing Activities growth rates for Johnson & Johnson have been -46% over the past three years , -3% over the past five years , and -10% over the past ten years .
You don't have any saved screeners yet
